Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Jan Wolber

GE Healthcare Pharmaceutical DiagnosticsDr Jan Wolber

Jan Wolber is Global Product Leader Digital at GE Healthcare. He is based in Amersham in the UK. His work is focused on Artificial Intelligence solutions for image assessment and clinical decision support across multiple disease areas. The development of digital biomarkers is an integral part of the Precision Health strategy of GE Healthcare.

Jan has 20 years of experience in medical imaging R&D as a scientist, project leader and departmental manager. After studying physics at the Universities of Bayreuth in Germany and St Andrews in Scotland, Jan received his PhD from the University of London in 2000 on work in the field of hyperpolarized 129Xe Magnetic Resonance (MR). He also has a MBA from Warwick Business School (graduation in 2014). Since 2012, Jan has held an honorary professorship in MR physics at the University of Sheffield alongside his employment at GE Healthcare. Jan has several links to Oxford University; he is chair of the External Advisory Board of the ONBI CDT and a member of the Scientific Management Committee of the SABS R3 CDT.

Jan has been involved across the innovation value chain of medical imaging from very early concepts to translational research, clinical studies and commercialisation. For instance, he was a key team member in the development and regulatory approval of GE Healthcare’s amyloid PET agent VizamylTM; his team led the imaging aspects of the development studies and developed the reading methodology for this tracer. He has also been involved in the development of image analysis software.

Please contact the Translational Research Office if you would like to arrange a meeting.

On this page